Live
- Woman’s False Claim Sparks Unnecessary Panic
- Locals Report Naxal Activity in Karkala Village
- Mangaluru International Airport Sets New Records in Passenger and Flight Movements
- Where Areca failed, grow Coffee
- Collector Badavath Santosh Reviews Household Survey and Listing Process
- Awareness Session on SHE Team and POCSO Act
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
'Delta' variant mutates into 'Delta Plus'
‘Delta’ variant mutates into ‘Delta Plus’
The 'Delta' variant of Covid-19 - a version first detected in India - has evolved to form the 'Delta Plus' or AY.1 variant
New Delhi: The 'Delta' variant of Covid-19 - a version first detected in India - has evolved to form the 'Delta Plus' or AY.1 variant. Scientists say it has acquired a mutation associated with escaping immunity but stress there is "no cause for concern yet".
The 'Delta Plus' variant is a mutated version of the more aggressive B.1.617.2 strain that drove the second wave of infections in India. It is characterised by the K417N mutation in the spike protein of the SARS-CoV2 virus that causes the Covid-19 disease.
The spike protein is what helps the virus enter and infect human cells, and the K417N mutation has been associated with immune escape, or evasion, that leaves it less susceptible, or more immune, to the vaccine or any form of drug therapy.
According to Public Health England, 63 B.1.617.2 genomes with the K417N mutation have been identified so far, six of which are from India.
There are 36 confirmed 'Delta Plus' cases in the UK and it accounts for around six per cent of cases in the US. Two UK cases were registered more than 14 days after the second vaccine dose, making them 'breakthrough' infections.
